CD44 inhibition attenuates EGFR signaling and enhances cisplatin sensitivity in human EGFR wild-type non-small-cell lung cancer cells

Cluster of differentiation 44 (CD44) as a transmembrane glycoprotein is found to be expressed in non-small cell lung cancer (NSCLC), is significantly associated with NSLC progression, metastasis and drug resistance. This study aimed to explore whether CD44 inhibition improves the sensitivity of epid...

Descripción completa

Detalles Bibliográficos
Autores principales: Yin, Jianhua, Zhang, Hanyu, Wu, Xu, Zhang, Yuchen, Li, Jing, Shen, Jing, Zhao, Yueshui, Xiao, Zhangang, Lu, Lan, Huang, Chengliang, Zhang, Zhuo, Du, Fukuan, Wu, Yuanlin, Kaboli, Parham Jabbarzadeh, Cho, Chi Hin, Yuan, Dandan, Li, Mingxing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7169661/
https://www.ncbi.nlm.nih.gov/pubmed/32236608
http://dx.doi.org/10.3892/ijmm.2020.4562

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7169661/
https://www.ncbi.nlm.nih.gov/pubmed/32236608
http://dx.doi.org/10.3892/ijmm.2020.4562

Ejemplares similares